147 related articles for article (PubMed ID: 35037352)
1. Letter to the editor regarding the article "Oguz Topal I, Kara Polat A, Zindancı İ, et al. Adherence to systemic therapy in patients with psoriasis during the COVID-19 pandemic: A multicenter study. J Cosmet Dermatol. 2021;10.1111/jocd.14610.".
Potestio L; Camela E; Tajani A; Fabbrocini G; Megna M
J Cosmet Dermatol; 2022 Mar; 21(3):880-882. PubMed ID: 35037352
[No Abstract] [Full Text] [Related]
2. Letter to the editor regarding article "Yalici-Armagan B, Tabak GH, Dogan-Gunaydin S, Gulseren D, Akdogan N, Atakan N. Treatment of psoriasis with biologics in the early COVID-19 pandemic: A study examining patient attitudes toward the treatment and disease course. J Cosmet Dermatol. 2021;00:1-5".
Potestio L; Camela E; Fabbrocini G; Megna M
J Cosmet Dermatol; 2021 Dec; 20(12):4073-4075. PubMed ID: 34708906
[No Abstract] [Full Text] [Related]
3. Letter to the editor regarding article "Falotico JM, Gu L, Lipner SR. Not just pimple popping: The utility of hybrid telemedicine models beyond acne management amidst the ongoing COVID-19 pandemic. J Cosmet Dermatol. 2022;10.1111/jocd.15256".
Potestio L; Villani A; Raia F; Fabbrocini G; Martora F
J Cosmet Dermatol; 2023 Mar; 22(3):1134-1135. PubMed ID: 36700374
[No Abstract] [Full Text] [Related]
4. Letter to the editor regarding the article ''Rossi A, Magri F, Michelini S, et al. New onset of alopecia areata in a patient with SARS-COV-2 infection: Possible pathogenetic correlations? J Cosmet Dermatol. 2021 Mar 19. doi: 10.1111/jocd.14080".
Abou-Rahal J; Abdullah L; Kurban M; Abbas O
J Cosmet Dermatol; 2021 Jun; 20(6):1951-1952. PubMed ID: 33853206
[No Abstract] [Full Text] [Related]
5. Letter to the editor regarding the article ''Patil S, Patil A. Systemic lupus erythematosus after COVID-19 vaccination: A case report. J Cosmet Dermatol. 2021 Aug 21. 10.1111/jocd.14386".
Abdullah L; Awada B; Kurban M; Abbas O
J Cosmet Dermatol; 2021 Dec; 20(12):4076-4077. PubMed ID: 34699662
[No Abstract] [Full Text] [Related]
6. Adherence to systemic therapy in patients with psoriasis during the COVID-19 pandemic: A multicenter study.
Oguz Topal I; Kara Polat A; Zindancı İ; Kıvanç Altunay İ; Akbulut TÖ; Arıkan EE; Topaloğlu Demir F; Sivaz O; Karadağ AS
J Cosmet Dermatol; 2022 Jan; 21(1):39-47. PubMed ID: 34792848
[TBL] [Abstract][Full Text] [Related]
7. Letter to the editor regarding article "Gu L, Diaz SM, Lipner SR. Retrospective study of acne telemedicine and in-person visits at an academic center during the COVID-19 pandemic. J Cosmet Dermatol. 2022;21(1):36-38.".
Potestio L; Fabbrocini G; Villani A
J Cosmet Dermatol; 2022 Nov; 21(11):6441-6442. PubMed ID: 35460317
[TBL] [Abstract][Full Text] [Related]
8. Surveillance of psoriatic patients on biologic treatment during the COVID-19 pandemic: A single-center experience.
Polat Ekinci A; Pehlivan G; Gökalp MO
Dermatol Ther; 2021 Jan; 34(1):e14700. PubMed ID: 33369063
[TBL] [Abstract][Full Text] [Related]
9. Letter to the editor regarding article "Hlaca N, Zagar T, Kastelan M, Peternel S, Brajac I, Prpic-Massari L. New-onset lichen planus and lichen planus flare in elderly women after COVID-19 vaccination. J Cosmet Dermatol. 2022;10.1111/jocd.15185".
Potestio L; Villani A; Fabbrocini G; Martora F
J Cosmet Dermatol; 2023 Jan; 22(1):39-41. PubMed ID: 36343163
[No Abstract] [Full Text] [Related]
10. Clinical management of psoriasis patients during the COVID-19 pandemic.
Chat VS; Uppal SK; Kearns DG; Wu JJ
J Dermatolog Treat; 2022 Mar; 33(2):1166-1167. PubMed ID: 32568009
[TBL] [Abstract][Full Text] [Related]
11. [BIOLOGICAL TREATMENT OF PSORIASIS IN TIME OF NEW CORONAVIRUS INFECTION COVID-19].
Kruglova LS; Pereverzina NO; Rudneva NS; Kamynina NN; Oynotkinova OS
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2021 Aug; 29(Special Issue):1381-1387. PubMed ID: 34792893
[TBL] [Abstract][Full Text] [Related]
12. Severe Acute Respiratory Syndrome Coronavirus 2 and the Use of Biologics in Patients With Psoriasis [Formula: see text].
Ladda M; Lynde C; Fleming P
J Cutan Med Surg; 2020; 24(6):625-632. PubMed ID: 32757760
[TBL] [Abstract][Full Text] [Related]
13. Is biologic treatment of hidradenitis suppurativa during the COVID-19 pandemic different from psoriasis biologic treatment?
Rosi E; Pimpinelli N; Prignano F
J Dermatolog Treat; 2022 Feb; 33(1):599. PubMed ID: 32432955
[No Abstract] [Full Text] [Related]
14. Influence of SARS-CoV-2 Virus Infection on the Course of Psoriasis during Treatment with Biological Drugs.
Mroz M; Mućka S; Miodońska M; Ziolkowska D; Hadas E; Bożek A
Medicina (Kaunas); 2021 Aug; 57(9):. PubMed ID: 34577804
[No Abstract] [Full Text] [Related]
15. A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic.
Hansel K; Zangrilli A; Bianchi L; Peris K; Chiricozzi A; Offidani A; Diotallevi F; Fargnoli MC; Esposito M; Amerio P; Gualdi G; Bianchi L; Stingeni L
J Eur Acad Dermatol Venereol; 2021 Mar; 35(3):e169-e170. PubMed ID: 33080112
[No Abstract] [Full Text] [Related]
16. Single-center survey of biologic use for inflammatory skin diseases during the coronavirus disease 2019 pandemic.
Kado S; Kamiya K; Kishimoto M; Maekawa T; Kuwahara A; Sugai J; Komine M; Ohtsuki M
J Dermatol; 2021 Dec; 48(12):1907-1912. PubMed ID: 34549456
[TBL] [Abstract][Full Text] [Related]
17. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
Hoşgelen EI; Alptekin K
Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34750798
[TBL] [Abstract][Full Text] [Related]
18. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
Hoşgelen EI; Alptekin K
Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34637131
[TBL] [Abstract][Full Text] [Related]
19. Compliance, safety concerns and anxiety in patients treated with biologics for psoriasis during the COVID-19 pandemic national lockdown: a multicenter study in the Czech Republic.
Rob F; Hugo J; Tivadar S; Boháč P; Gkalpakiotis S; Vargová N; Arenbergerová M; Hercogová J
J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):e682-e684. PubMed ID: 32594549
[No Abstract] [Full Text] [Related]
20. Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: A Canadian multicenter retrospective study.
Georgakopoulos JR; Mufti A; Vender R; Yeung J
J Am Acad Dermatol; 2020 Oct; 83(4):1212-1214. PubMed ID: 32679279
[No Abstract] [Full Text] [Related]
[Next] [New Search]
